首页 > 最新文献

Australian & New Zealand Journal of Obstetrics & Gynaecology最新文献

英文 中文
Main Program Abstracts 2024年10月14-16日。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-13 DOI: 10.1111/ajo.13921
{"title":"Main Program Abstracts","authors":"","doi":"10.1111/ajo.13921","DOIUrl":"10.1111/ajo.13921","url":null,"abstract":"","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":"65 S1","pages":"4-33"},"PeriodicalIF":1.4,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajo.13921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Static Poster Abstracts 2024年10月14-16日。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-13 DOI: 10.1111/ajo.2_13921
{"title":"Static Poster Abstracts","authors":"","doi":"10.1111/ajo.2_13921","DOIUrl":"10.1111/ajo.2_13921","url":null,"abstract":"","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":"65 S1","pages":"40-53"},"PeriodicalIF":1.4,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajo.2_13921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three Minute Thesis Abstracts 2024年10月14-16日。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-13 DOI: 10.1111/ajo.1_13921
{"title":"Three Minute Thesis Abstracts","authors":"","doi":"10.1111/ajo.1_13921","DOIUrl":"10.1111/ajo.1_13921","url":null,"abstract":"","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":"65 S1","pages":"33-40"},"PeriodicalIF":1.4,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajo.1_13921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Screening should not be based on ability to pay': Australian healthcare providers' and consumers' perspectives on public funding for non-invasive prenatal testing. “筛查不应基于支付能力”:澳大利亚医疗保健提供者和消费者对非侵入性产前检测公共资金的看法。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-13 DOI: 10.1111/ajo.13915
Cecilia Pynaker, Molly Johnston, Catherine Mills, Katie Vasey, Michelle Taylor-Sands, Hilary Bowman-Smart, Lisa Hui

Background: Non-invasive prenatal testing (NIPT) does not receive any Medicare rebate. This study investigated the views of Australian healthcare providers and consumers on public funding of NIPT.

Materials and methods: Two anonymous online, cross-sectional surveys were conducted from September 2022 to January 2023. Surveys targeted maternity healthcare professionals ('providers'), and individuals who had recently conceived a pregnancy ('consumers'). Quantitative data were analysed using χ2 test. Free-text responses were analysed by inductive content analysis.

Results: Responses from 381 providers and 630 consumers were analysed. The overwhelming majority of providers (96.8%) identified financial cost as a consumer barrier to NIPT access. Public funding for NIPT was supported by 86.4% of providers and 90.4% of consumers, with free-text responses citing equity, clinical, health economic, reproductive autonomy, and ethical justifications. Of the 145 consumers who did not use NIPT in a recent pregnancy, 63.1% rated cost as an 'important/very important' factor in foregoing NIPT. NIPT non-users were younger, had lower household income and education, and were more likely to live in a rural or remote area than consumers who used NIPT.

Conclusion: Maternity healthcare providers and consumers are highly supportive of public funding for NIPT as a first-line screening test on clinical, equity, health economic, and ethical grounds. Our results confirm the presence of significant socioeconomic disparities between NIPT users and non-users, with cost being the most important factor impeding equitable access to best practice in prenatal screening. Further research and advocacy are needed to achieve equitable access to best practice in antenatal care.

背景:无创产前检查(NIPT)不接受任何医疗保险回扣。本研究调查了澳大利亚医疗保健提供者和消费者对NIPT公共资金的看法。材料和方法:从2022年9月到2023年1月进行了两次匿名的在线横断面调查。调查的对象是产妇保健专业人员(“提供者”)和最近怀孕的个人(“消费者”)。定量资料采用χ2检验。采用归纳内容分析法对自由文本回复进行分析。结果:对381家供应商和630名消费者的反馈进行了分析。绝大多数供应商(96.8%)认为财务成本是消费者使用NIPT的障碍。对NIPT的公共资助得到了86.4%的提供者和90.4%的消费者的支持,自由文本回应引用了公平、临床、健康经济、生殖自主和道德理由。在145名最近怀孕期间没有使用NIPT的消费者中,63.1%的人认为成本是放弃NIPT的“重要/非常重要”因素。与使用NIPT的消费者相比,不使用NIPT的人更年轻,家庭收入和教育程度较低,更有可能生活在农村或偏远地区。结论:从临床、公平、卫生经济和伦理角度考虑,产妇保健提供者和消费者高度支持为NIPT提供公共资金作为一线筛查试验。我们的研究结果证实了NIPT使用者和非使用者之间存在显著的社会经济差异,成本是阻碍公平获得产前筛查最佳实践的最重要因素。需要进一步的研究和宣传,以实现公平获得产前保健最佳做法。
{"title":"'Screening should not be based on ability to pay': Australian healthcare providers' and consumers' perspectives on public funding for non-invasive prenatal testing.","authors":"Cecilia Pynaker, Molly Johnston, Catherine Mills, Katie Vasey, Michelle Taylor-Sands, Hilary Bowman-Smart, Lisa Hui","doi":"10.1111/ajo.13915","DOIUrl":"https://doi.org/10.1111/ajo.13915","url":null,"abstract":"<p><strong>Background: </strong>Non-invasive prenatal testing (NIPT) does not receive any Medicare rebate. This study investigated the views of Australian healthcare providers and consumers on public funding of NIPT.</p><p><strong>Materials and methods: </strong>Two anonymous online, cross-sectional surveys were conducted from September 2022 to January 2023. Surveys targeted maternity healthcare professionals ('providers'), and individuals who had recently conceived a pregnancy ('consumers'). Quantitative data were analysed using χ<sup>2</sup> test. Free-text responses were analysed by inductive content analysis.</p><p><strong>Results: </strong>Responses from 381 providers and 630 consumers were analysed. The overwhelming majority of providers (96.8%) identified financial cost as a consumer barrier to NIPT access. Public funding for NIPT was supported by 86.4% of providers and 90.4% of consumers, with free-text responses citing equity, clinical, health economic, reproductive autonomy, and ethical justifications. Of the 145 consumers who did not use NIPT in a recent pregnancy, 63.1% rated cost as an 'important/very important' factor in foregoing NIPT. NIPT non-users were younger, had lower household income and education, and were more likely to live in a rural or remote area than consumers who used NIPT.</p><p><strong>Conclusion: </strong>Maternity healthcare providers and consumers are highly supportive of public funding for NIPT as a first-line screening test on clinical, equity, health economic, and ethical grounds. Our results confirm the presence of significant socioeconomic disparities between NIPT users and non-users, with cost being the most important factor impeding equitable access to best practice in prenatal screening. Further research and advocacy are needed to achieve equitable access to best practice in antenatal care.</p>","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between COVID-19 Pandemic Phases and the Risk of Maternal Intensive Care Unit Admission: A Retrospective Analysis of 215,363 Victorian Hospital Admissions. COVID-19大流行阶段与孕产妇重症监护病房入院风险之间的关系:对维多利亚州215,363例入院患者的回顾性分析
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-02 DOI: 10.1111/ajo.13931
Michele Barrese, Melvin B Marzan, Lisa Hui

Background: There are no published Australian population-based data on serious COVID-19-associated maternal morbidity before and after widespread vaccination.

Aims: To compare COVID-19 infection rates, intensive care unit (ICU) admissions, and length of stay in hospitalised pregnant patients before and after achieving 70% state-wide maternal COVID-19 vaccination coverage.

Material and methods: Population-based retrospective cohort study involving all hospital-admitted episodes for pregnant patients over 15-years-old with COVID-19 in Victoria from 1 March 2020 to 31 March 2022. Phase 1 was defined as March 2020-October 2021 when maternal vaccination coverage < 70%; Phase 2 was defined as November 2021-March 2022 when maternal vaccination coverage ≥ 70%. Primary outcomes include COVID-19 rates, ICU admission rates, and length of stay. A p-value of < 0.05 was considered statistically significant.

Results: We analysed 215,363 hospital admissions, among which 2,128 (0.99%) had COVID-19. The percentage of admitted pregnant patients with COVID-19 was higher in Phase 2 than Phase 1 (3.27% vs. 0.41% respectively, p < 0.001). However, Phase 2 was associated with lower maternal ICU admission rates (2.02% vs. 5.39%, p < 0.001) and lower median length of stay (2.19 vs. 3.11 days, p < 0.001) compared with Phase 1. The risk of COVID-19 was significantly lower in socioeconomically advantaged pregnant patients (aRR = 0.83 [95% CI, 0.76-0.90], p < 0.001) and pregnant patients ≥ 30-years-old (aRR = 0.81 [95% CI, 0.74-0.88], p < 0.001).

Conclusions: Maternal ICU admission risk and length of stay were significantly lower among pregnant patients with COVID-19 during Phase 2, which is likely due to the combined effects of high maternal COVID-19 vaccination coverage and changes in SARS-CoV-2 variants.

背景:在广泛接种疫苗前后,澳大利亚没有公布的基于人群的covid -19相关严重孕产妇发病率数据。目的:比较全国孕产妇COVID-19疫苗接种率达到70%前后住院孕妇的COVID-19感染率、重症监护病房(ICU)入院率和住院时间。材料和方法:基于人群的回顾性队列研究,涉及2020年3月1日至2022年3月31日在维多利亚州所有住院的15岁以上COVID-19孕妇。第一阶段定义为2020年3月至2021年10月,孕产妇疫苗接种覆盖率。结果:我们分析了215,363例住院患者,其中2128例(0.99%)患有COVID-19。结论:2期妊娠COVID-19患者入院风险和住院时间均明显低于1期(3.27% vs. 0.41%),这可能与孕产妇COVID-19疫苗接种率高和SARS-CoV-2变异的变化共同作用。
{"title":"Association Between COVID-19 Pandemic Phases and the Risk of Maternal Intensive Care Unit Admission: A Retrospective Analysis of 215,363 Victorian Hospital Admissions.","authors":"Michele Barrese, Melvin B Marzan, Lisa Hui","doi":"10.1111/ajo.13931","DOIUrl":"https://doi.org/10.1111/ajo.13931","url":null,"abstract":"<p><strong>Background: </strong>There are no published Australian population-based data on serious COVID-19-associated maternal morbidity before and after widespread vaccination.</p><p><strong>Aims: </strong>To compare COVID-19 infection rates, intensive care unit (ICU) admissions, and length of stay in hospitalised pregnant patients before and after achieving 70% state-wide maternal COVID-19 vaccination coverage.</p><p><strong>Material and methods: </strong>Population-based retrospective cohort study involving all hospital-admitted episodes for pregnant patients over 15-years-old with COVID-19 in Victoria from 1 March 2020 to 31 March 2022. Phase 1 was defined as March 2020-October 2021 when maternal vaccination coverage < 70%; Phase 2 was defined as November 2021-March 2022 when maternal vaccination coverage ≥ 70%. Primary outcomes include COVID-19 rates, ICU admission rates, and length of stay. A p-value of < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>We analysed 215,363 hospital admissions, among which 2,128 (0.99%) had COVID-19. The percentage of admitted pregnant patients with COVID-19 was higher in Phase 2 than Phase 1 (3.27% vs. 0.41% respectively, p < 0.001). However, Phase 2 was associated with lower maternal ICU admission rates (2.02% vs. 5.39%, p < 0.001) and lower median length of stay (2.19 vs. 3.11 days, p < 0.001) compared with Phase 1. The risk of COVID-19 was significantly lower in socioeconomically advantaged pregnant patients (aRR = 0.83 [95% CI, 0.76-0.90], p < 0.001) and pregnant patients ≥ 30-years-old (aRR = 0.81 [95% CI, 0.74-0.88], p < 0.001).</p><p><strong>Conclusions: </strong>Maternal ICU admission risk and length of stay were significantly lower among pregnant patients with COVID-19 during Phase 2, which is likely due to the combined effects of high maternal COVID-19 vaccination coverage and changes in SARS-CoV-2 variants.</p>","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142916556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Antepartum Haemorrhage in Women With Placenta Praevia. 前置胎盘妇女产前出血的危险因素分析。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-02 DOI: 10.1111/ajo.13925
A Treffers, O Reynoldson, M Beckmann

Background: Placenta praevia (PP) is a significant obstetric complication associated with antepartum haemorrhage (APH) and adverse maternal and fetal outcomes. Identifying risk factors for APH in women with PP is important for guiding management decisions.

Aims: This study aimed to identify risk factors associated with APH amongst women admitted to a single tertiary hospital with PP.

Materials and methods: A retrospective cohort study was undertaken, utilising data from the hospital's maternity dataset (2007-2021) and included publicly funded women with PP after 24 weeks gestation. Exclusions comprised multiple pregnancies, fetal abnormalities, intra-uterine fetal death and deliveries at other hospitals. Baseline characteristics, outcomes and potential risk factors for APH were analysed through bivariate and stepwise logistic regression.

Results: Of the 430 cases with PP, 112 (26%) were admitted with APH. Of these, 45 had two or more admissions with APH, constituting 40% of the APH cohort. Those requiring admission were more likely to deliver at an early gestation, and their baby required nursery admission. Factors independently associated with APH included a higher number of previous caesarean sections, parity, Caucasian ethnicity and major PP.

Conclusions: Most women with PP will not require an admission with APH. In considering inpatient versus outpatient management, multiparous Caucasian women with a major PP appear more likely to be at risk of APH admission and premature delivery. These findings underscore the importance of tailoring clinical decision-making.

背景:前置胎盘(PP)是一种重要的产科并发症,与产前出血(APH)和不良母婴结局相关。识别妊高征女性APH的危险因素对指导管理决策具有重要意义。目的:本研究旨在确定在一家三级医院住院的PP妇女中与APH相关的危险因素。材料和方法:进行了一项回顾性队列研究,利用该医院产妇数据集(2007-2021)的数据,包括24周妊娠后的PP妇女。排除包括多胎妊娠、胎儿异常、子宫内胎儿死亡和在其他医院分娩。通过双变量和逐步logistic回归分析APH的基线特征、结局和潜在危险因素。结果:430例PP患者中,有112例(26%)合并APH入院。其中,45人有两次或两次以上的APH录取,占APH队列的40%。那些需要入院的人更有可能在妊娠早期分娩,他们的孩子需要托儿所入院。与APH独立相关的因素包括较高的剖宫产史、产次、高加索人种和重度妊高征。结论:大多数妊高征妇女不需要入院接受妊高征。在考虑住院治疗和门诊治疗时,患有严重PP的多胎白人妇女似乎更有可能出现APH入院和早产的风险。这些发现强调了定制临床决策的重要性。
{"title":"Risk Factors for Antepartum Haemorrhage in Women With Placenta Praevia.","authors":"A Treffers, O Reynoldson, M Beckmann","doi":"10.1111/ajo.13925","DOIUrl":"https://doi.org/10.1111/ajo.13925","url":null,"abstract":"<p><strong>Background: </strong>Placenta praevia (PP) is a significant obstetric complication associated with antepartum haemorrhage (APH) and adverse maternal and fetal outcomes. Identifying risk factors for APH in women with PP is important for guiding management decisions.</p><p><strong>Aims: </strong>This study aimed to identify risk factors associated with APH amongst women admitted to a single tertiary hospital with PP.</p><p><strong>Materials and methods: </strong>A retrospective cohort study was undertaken, utilising data from the hospital's maternity dataset (2007-2021) and included publicly funded women with PP after 24 weeks gestation. Exclusions comprised multiple pregnancies, fetal abnormalities, intra-uterine fetal death and deliveries at other hospitals. Baseline characteristics, outcomes and potential risk factors for APH were analysed through bivariate and stepwise logistic regression.</p><p><strong>Results: </strong>Of the 430 cases with PP, 112 (26%) were admitted with APH. Of these, 45 had two or more admissions with APH, constituting 40% of the APH cohort. Those requiring admission were more likely to deliver at an early gestation, and their baby required nursery admission. Factors independently associated with APH included a higher number of previous caesarean sections, parity, Caucasian ethnicity and major PP.</p><p><strong>Conclusions: </strong>Most women with PP will not require an admission with APH. In considering inpatient versus outpatient management, multiparous Caucasian women with a major PP appear more likely to be at risk of APH admission and premature delivery. These findings underscore the importance of tailoring clinical decision-making.</p>","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142916557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the First Laparoscopy in an Adolescent and Young Adult Female Population and Its Association With Chronic Pelvic Pain: A Randomised Controlled Trial. 青少年和年轻成年女性首次腹腔镜检查的效果及其与慢性盆腔疼痛的关系:一项随机对照试验。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-31 DOI: 10.1111/ajo.13930
Kimberly Nguyen, Joyce Wu, Hayley Mallinder, Madhulikaa Sarjapuram Niranjan, Brigitte Gerstl, Jason A Abbott, Rebecca Deans

Background: Chronic pelvic pain (CPP) is a common and debilitating presentation for adolescent and young adult females. Medical management is often utilised as first line therapy with surgical management considered if medical treatment has been unsuccessful. Laparoscopy in this young population remains controversial due to the high recurrence rate of pain, requirement for repeat surgeries and surgical risks. There is a need for prospective, longitudinal studies comparing medical and surgical management to guide management of young patients with CPP.

Aims: To determine the effect of the first laparoscopy in an adolescent and young adult female population and assess its association with CPP.

Materials and methods: Patients aged 16-25 will be recruited from the gynaecological service at the study sites. Consented participants will be randomised to the surgical or non-surgical arms. Those in the surgical arm will have a laparoscopy performed and those in the non-surgical arm will be medically managed. At recruitment and at 6 weeks, 6 months, 12 months and 24 months follow-up, patients will complete a number of validated questionnaires assessing pain and quality of life. An amendment was made to methodology to include patients who will choose their management pathway for CPP.

Results: An independent t-test or Mann-Whitney U test will be used to compare the questionnaire scores between the surgical and non-surgical groups. For questionnaire scores at baseline and follow-up within the same arm, a paired t-test or Wilcoxon signed-rank test will be used. A p-value of < 0.05 will be statistically significant.

背景:慢性骨盆疼痛(CPP)是青少年和年轻成年女性的一种常见和衰弱的表现。医疗管理通常被用作第一线治疗,如果药物治疗不成功,则考虑手术管理。由于疼痛的高复发率,需要重复手术和手术风险,腹腔镜手术在这一年轻人群中仍然存在争议。有必要进行前瞻性、纵向研究,比较内科和外科治疗,以指导年轻CPP患者的治疗。目的:确定青少年和年轻成年女性首次腹腔镜手术的效果,并评估其与CPP的关系。材料和方法:年龄16-25岁的患者将从研究地点的妇科服务部门招募。同意的参与者将被随机分配到手术组或非手术组。那些在手术臂的人将进行腹腔镜检查,而那些在非手术臂的人将进行医疗管理。在招募和6周、6个月、12个月和24个月的随访中,患者将完成一系列有效的评估疼痛和生活质量的问卷。对方法进行了修改,以纳入将选择其CPP管理途径的患者。结果:手术组与非手术组问卷得分比较采用独立t检验或Mann-Whitney U检验。对于同一组基线和随访时的问卷得分,将使用配对t检验或Wilcoxon sign -rank检验。的p值
{"title":"Effect of the First Laparoscopy in an Adolescent and Young Adult Female Population and Its Association With Chronic Pelvic Pain: A Randomised Controlled Trial.","authors":"Kimberly Nguyen, Joyce Wu, Hayley Mallinder, Madhulikaa Sarjapuram Niranjan, Brigitte Gerstl, Jason A Abbott, Rebecca Deans","doi":"10.1111/ajo.13930","DOIUrl":"https://doi.org/10.1111/ajo.13930","url":null,"abstract":"<p><strong>Background: </strong>Chronic pelvic pain (CPP) is a common and debilitating presentation for adolescent and young adult females. Medical management is often utilised as first line therapy with surgical management considered if medical treatment has been unsuccessful. Laparoscopy in this young population remains controversial due to the high recurrence rate of pain, requirement for repeat surgeries and surgical risks. There is a need for prospective, longitudinal studies comparing medical and surgical management to guide management of young patients with CPP.</p><p><strong>Aims: </strong>To determine the effect of the first laparoscopy in an adolescent and young adult female population and assess its association with CPP.</p><p><strong>Materials and methods: </strong>Patients aged 16-25 will be recruited from the gynaecological service at the study sites. Consented participants will be randomised to the surgical or non-surgical arms. Those in the surgical arm will have a laparoscopy performed and those in the non-surgical arm will be medically managed. At recruitment and at 6 weeks, 6 months, 12 months and 24 months follow-up, patients will complete a number of validated questionnaires assessing pain and quality of life. An amendment was made to methodology to include patients who will choose their management pathway for CPP.</p><p><strong>Results: </strong>An independent t-test or Mann-Whitney U test will be used to compare the questionnaire scores between the surgical and non-surgical groups. For questionnaire scores at baseline and follow-up within the same arm, a paired t-test or Wilcoxon signed-rank test will be used. A p-value of < 0.05 will be statistically significant.</p>","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142911232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How We Really WHO: Assessing Completeness, Team Engagement, Distractions and Authority Gradient During 'Time Out' Component of WHO Safer Surgery Checklist. 我们如何真正的WHO:评估完整性,团队参与,在WHO安全手术清单的“暂停”部分分心和权力梯度。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-30 DOI: 10.1111/ajo.13924
Wai Yoong, Suzanne Reilly, Hashviniya Sekar, Frishta Abdul Ali, Tasnim Khonkon, Fan Zhang, Kiran Suleman, Maud Nauta

Background: Anecdotal experience suggests that WHO Safer Surgery Checklist has become a 'tickbox' exercise, resulting in variable team engagement and efficacy.

Aims: To observe the quality and completeness of 'Time Out', together with the level of team engagement during obstetrics and gynaecology procedures.

Materials and methods: Observational study where the following data were collected during 'Time Out': % of the 19 items correctly responded to after 'challenge'. Type and duration of distractions. Level of team engagement. Authority gradient and likelihood of speaking up (Visual Analogue Score).

Results: Data from 70 obstetrics and gynaecology cases were collected over 8 weeks. 'Time Out' was clearly announced in 91.4% and was performed in all cases but not all items were communicated in the correct 'challenge and response' manner. Mean percentage of questions appropriately 'challenged' and 'responded' to was 92% ± 6.86%. Mean duration of 'Time Out' was 92.01 ± 86.9 s and observed distractions were auditory (61%), visual (26%), irrelevant chatter (22.5%) and theatre traffic (13%). In 92.8%, at least two team members were not engaged and were performing non-essential tasks. The likelihood of a team member being able to 'speak up' was 8.78/10 (±0.71) and this appeared independent of whether it was led by nurses, doctors, operating department practitioners or healthcare support workers.

Conclusion: Although performed in all cases, 'Time Out' is often not clearly announced or completed in the correct 'challenge and response' manner. It is plagued by avoidable distractions and suboptimal team engagement. Greater awareness is crucial to ensure more complete team involvement.

背景:轶事经验表明,世卫组织更安全手术核对表已成为一项“打勾”的工作,导致团队参与程度和效率各不相同。目的:观察“暂停”的质量和完整性,以及产科和妇科手术过程中的团队参与水平。材料和方法:观察性研究,在“暂停”期间收集以下数据:在“挑战”后,19个项目中正确回答的百分比。分心的类型和持续时间。团队参与程度。权威梯度和发言的可能性(视觉模拟分数)。结果:在8周内收集了70例妇产科病例的资料。91.4%的人清楚地宣布了“暂停”,并且在所有情况下都执行了“暂停”,但并非所有项目都以正确的“挑战和回应”方式进行了沟通。恰当地“挑战”和“回应”问题的平均百分比为92%±6.86%。“暂停”的平均持续时间为92.01±86.9秒,观察到的干扰包括听觉(61%)、视觉(26%)、无关的闲聊(22.5%)和剧院交通(13%)。在92.8%中,至少有两名团队成员没有参与,并且正在执行非必要的任务。团队成员能够“畅所欲言”的可能性是8.78/10(±0.71),这与领导团队的是护士、医生、手术部门从业人员还是医疗保健支持人员无关。结论:虽然在所有情况下都进行了“暂停”,但通常没有明确宣布或以正确的“挑战和回应”方式完成。它受到本可避免的干扰和不理想的团队参与的困扰。更强的意识对于确保更全面的团队参与至关重要。
{"title":"How We Really WHO: Assessing Completeness, Team Engagement, Distractions and Authority Gradient During 'Time Out' Component of WHO Safer Surgery Checklist.","authors":"Wai Yoong, Suzanne Reilly, Hashviniya Sekar, Frishta Abdul Ali, Tasnim Khonkon, Fan Zhang, Kiran Suleman, Maud Nauta","doi":"10.1111/ajo.13924","DOIUrl":"https://doi.org/10.1111/ajo.13924","url":null,"abstract":"<p><strong>Background: </strong>Anecdotal experience suggests that WHO Safer Surgery Checklist has become a 'tickbox' exercise, resulting in variable team engagement and efficacy.</p><p><strong>Aims: </strong>To observe the quality and completeness of 'Time Out', together with the level of team engagement during obstetrics and gynaecology procedures.</p><p><strong>Materials and methods: </strong>Observational study where the following data were collected during 'Time Out': % of the 19 items correctly responded to after 'challenge'. Type and duration of distractions. Level of team engagement. Authority gradient and likelihood of speaking up (Visual Analogue Score).</p><p><strong>Results: </strong>Data from 70 obstetrics and gynaecology cases were collected over 8 weeks. 'Time Out' was clearly announced in 91.4% and was performed in all cases but not all items were communicated in the correct 'challenge and response' manner. Mean percentage of questions appropriately 'challenged' and 'responded' to was 92% ± 6.86%. Mean duration of 'Time Out' was 92.01 ± 86.9 s and observed distractions were auditory (61%), visual (26%), irrelevant chatter (22.5%) and theatre traffic (13%). In 92.8%, at least two team members were not engaged and were performing non-essential tasks. The likelihood of a team member being able to 'speak up' was 8.78/10 (±0.71) and this appeared independent of whether it was led by nurses, doctors, operating department practitioners or healthcare support workers.</p><p><strong>Conclusion: </strong>Although performed in all cases, 'Time Out' is often not clearly announced or completed in the correct 'challenge and response' manner. It is plagued by avoidable distractions and suboptimal team engagement. Greater awareness is crucial to ensure more complete team involvement.</p>","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142911234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: Tolerance, Decision-Making Processes and Medication Trials in Pregnancy. 回复:妊娠耐受、决策过程和药物试验。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-30 DOI: 10.1111/ajo.13927
Eva Quattrini, Demelza J Ireland, Jeffrey A Keelan
{"title":"Reply to: Tolerance, Decision-Making Processes and Medication Trials in Pregnancy.","authors":"Eva Quattrini, Demelza J Ireland, Jeffrey A Keelan","doi":"10.1111/ajo.13927","DOIUrl":"https://doi.org/10.1111/ajo.13927","url":null,"abstract":"","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142911238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor-In-Chief's Introduction to ANZJOG 64(6) 主编介绍ANZJOG 64(6)。
IF 1.4 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-30 DOI: 10.1111/ajo.13923
Scott W. White
<p>Welcome to the final issue of <i>ANZJOG</i> for 2024.</p><p>This has been another busy year for the <i>Journal</i> with a significant increase in the number of submissions. While this is welcome, it does come with increased burden upon the voluntary workforce that maintains the academic rigour of the publication, specifically the Associate Editors and Peer Reviewers. These generally thankless roles are vital to the ongoing viability of a local scientific journal for our field, and I am immensely grateful to those clinicians and academics who make these contributions—<i>ANZJOG</i> would literally not exist without you. I wish to acknowledge the dedication and support of the Editorial Board who give so generously of their time and expertise. Thank you.</p><p><i>ANZJOG</i> is proud to provide a forum for the dissemination of locally relevant obstetrics and gynaecology research. It is through the support of authors choosing <i>ANZJOG</i> as the home for their work that allows the <i>Journal</i> to continue and to grow. Ultimately, this can only advance the science behind the work that us clinicians do, to the benefit of the communities that we serve. Without authors submitting their high-quality manuscripts, this would not be possible. I am aware that journal submissions and the peer review process can be at times tedious, frustrating and delayed. RANZCOG are please to have reappointed Wiley as the publisher for <i>ANZJOG</i>, and I am excited to be able to work with Wiley in implementing several new initiatives in the coming year, which promise to improve the author and reader experience of the <i>Journal</i>.</p><p>This issue features an editorial by Kirsten Connan [<span>1</span>] discussing the progress in gender-equitable representation in obstetrics and gynaecology leadership in Australia and Aotearoa New Zealand. Contrasting the findings of her earlier work [<span>2</span>] with that of Holmes, Ibiebele, and Nippita [<span>3</span>] more recently, Connan describes the commendable improvements in gender equity in RANZCOG and clinical departmental leadership positions over a relatively short period of time. This change goes beyond the ‘pipeline’ effect of an increasingly female RANZCOG Fellowship and reflects the deliberate efforts of senior College representatives and staff in identifying and removing barriers to gender equity in college bodies. RANZCOG has dual roles in representing it members as a member-based organisation and also in advocating for the community which we serve, unique among all medical colleges in being heavily gender-specific, making gender diversity particularly relevant. Connan also highlights the other important diversity considerations, which are also worthy of addressing, particularly those such as First Nations, Māori, migrant, other culturally and linguistically diverse communities, and the LGBTQIA+ community, as these groups often face disproportionately poor health outcomes in our field. RANZCOG's progress so fa
{"title":"Editor-In-Chief's Introduction to ANZJOG 64(6)","authors":"Scott W. White","doi":"10.1111/ajo.13923","DOIUrl":"10.1111/ajo.13923","url":null,"abstract":"&lt;p&gt;Welcome to the final issue of &lt;i&gt;ANZJOG&lt;/i&gt; for 2024.&lt;/p&gt;&lt;p&gt;This has been another busy year for the &lt;i&gt;Journal&lt;/i&gt; with a significant increase in the number of submissions. While this is welcome, it does come with increased burden upon the voluntary workforce that maintains the academic rigour of the publication, specifically the Associate Editors and Peer Reviewers. These generally thankless roles are vital to the ongoing viability of a local scientific journal for our field, and I am immensely grateful to those clinicians and academics who make these contributions—&lt;i&gt;ANZJOG&lt;/i&gt; would literally not exist without you. I wish to acknowledge the dedication and support of the Editorial Board who give so generously of their time and expertise. Thank you.&lt;/p&gt;&lt;p&gt;&lt;i&gt;ANZJOG&lt;/i&gt; is proud to provide a forum for the dissemination of locally relevant obstetrics and gynaecology research. It is through the support of authors choosing &lt;i&gt;ANZJOG&lt;/i&gt; as the home for their work that allows the &lt;i&gt;Journal&lt;/i&gt; to continue and to grow. Ultimately, this can only advance the science behind the work that us clinicians do, to the benefit of the communities that we serve. Without authors submitting their high-quality manuscripts, this would not be possible. I am aware that journal submissions and the peer review process can be at times tedious, frustrating and delayed. RANZCOG are please to have reappointed Wiley as the publisher for &lt;i&gt;ANZJOG&lt;/i&gt;, and I am excited to be able to work with Wiley in implementing several new initiatives in the coming year, which promise to improve the author and reader experience of the &lt;i&gt;Journal&lt;/i&gt;.&lt;/p&gt;&lt;p&gt;This issue features an editorial by Kirsten Connan [&lt;span&gt;1&lt;/span&gt;] discussing the progress in gender-equitable representation in obstetrics and gynaecology leadership in Australia and Aotearoa New Zealand. Contrasting the findings of her earlier work [&lt;span&gt;2&lt;/span&gt;] with that of Holmes, Ibiebele, and Nippita [&lt;span&gt;3&lt;/span&gt;] more recently, Connan describes the commendable improvements in gender equity in RANZCOG and clinical departmental leadership positions over a relatively short period of time. This change goes beyond the ‘pipeline’ effect of an increasingly female RANZCOG Fellowship and reflects the deliberate efforts of senior College representatives and staff in identifying and removing barriers to gender equity in college bodies. RANZCOG has dual roles in representing it members as a member-based organisation and also in advocating for the community which we serve, unique among all medical colleges in being heavily gender-specific, making gender diversity particularly relevant. Connan also highlights the other important diversity considerations, which are also worthy of addressing, particularly those such as First Nations, Māori, migrant, other culturally and linguistically diverse communities, and the LGBTQIA+ community, as these groups often face disproportionately poor health outcomes in our field. RANZCOG's progress so fa","PeriodicalId":55429,"journal":{"name":"Australian & New Zealand Journal of Obstetrics & Gynaecology","volume":"64 6","pages":"537-539"},"PeriodicalIF":1.4,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajo.13923","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142911240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Australian & New Zealand Journal of Obstetrics & Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1